[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:kdr-wt-allele":3},{"name":4,"total":5,"recruiting":5,"trials":6},"KDR wt Allele",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05168618","Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer",[11],"Phase 2","RECRUITING","2026-08-26T02:17:17.791881Z","2026-07-05T05:32:16.800551Z"]